MARKETSnap
  • Market Snapshots
    • Gainers & Losers
    • Most Active & More
    • 52-Week High/Low
    • Dividends
    • P/E Ratios
      • Large Caps
      • Absolute
      • Total Market PE
    • Stocks Performance
      • Large Caps
      • Absolute
    • Industries Performance
      • Industry
      • Sector
  • Analyze Stock
    • Analyze a stockAnalyze MCK →
    • FindStock Picks / Stock Screener
    • Value · MCKIntrinsic Value Calculator
    • Invest · MCKInvestment Case
    • Hold · MCK5-Year Outlook
  • Learn
  • Calendar
  • Investment Compounding
    Calculator
  • Investing Philosophy
  • More
    • Charts
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
MCK stock logo

MCK

McKesson Corporation

$1102.81
25.76
 (2.39%)
Exchange:  NYSE
Market Cap:  127.327B
Shares Outstanding:  123.6M
Delayed data
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  HealthcareView sector performance
Industry:  Medical – DistributionView industry performance
   
CEO:  Brian S. Tyler
Full Time Employees:  42300
Address: 
6555 State Highway 161
Irving
TX
75039
US
Website:  https://www.mckesson.com
McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key business segments. The U.S. Pharmaceutical division plays a crucial role in the distribution of a comprehensive array of pharmaceutical products, encompassing branded, generic, specialty, biosimilar, and over-the-counter medications, alongside other health-related merchandise. This segment also delivers specialized support to community-based oncology and other specialty medical practices through practice management tools, technology solutions, clinical guidance, and broader business services. Furthermore, it assists pharmacies with consulting, outsourcing, and technology services, while also furnishing financial, operational, and clinical software solutions. Internationally, the company’s dedicated segment provides distribution and support services to wholesale, institutional, and retail clients across 13 European nations and Canada. The Medical-Surgical Solutions unit is focused on supplying healthcare providers with essential medical-surgical products, sophisticated logistics management, and a variety of associated services. Finally, the Prescription Technology Solutions (RxTS) segment is designed to address complex medication challenges for patients. It collaborates with biopharmaceutical companies and life sciences partners to improve patient journeys, leveraging innovative solutions for medication access and adherence by connecting pharmacies, healthcare providers, payers, and biopharma entities. This segment further offers third-party logistics and wholesale distribution assistance. Founded in 1833, McKesson Corporation maintains its corporate headquarters in Irving, Texas.

Click to read more…

Revenue Segmentation

Revenue by type

Revenue by region

Log in to continue

Log in to see the complete revenue and geographic breakdown.

Log in — it's free

Industry Peers

TICKERCOMPANYMKT CAPP/EFWD P/EROIC
MCMCK logoMCKMcKesson Corporation127.3B28.228.329.3%
COCOR logoCORCencora, Inc.68.5B20.020.113.5%
CACAH logoCAHCardinal Health, Inc.65.0B36.226.114.3%
HSHSIC logoHSICHenry Schein, Inc.9.5B23.415.66.5%
AHAHG logoAHGAkso Health Group1.1B—0.3-1.9%
ZYZYXI logoZYXIZynex, Inc.4.1M——243.4%

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Log in — it's free
View full analyst estimates

Earnings Call

Full text

Earnings transcript

Read the complete earnings call transcript.

AI summary

Key takeaways

Short, structured highlights from the call so you can focus on what matters.

2026/08/05 — 1 quarter 2027

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Log in — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202420252026
Revenue308,951,000359,051,000403,430,000
Gross Profit12,202,00012,485,00014,550,000
EBITDA4,667,0005,251,0007,177,000
Operating Income3,927,0004,372,0006,454,000
Net Income3,002,0003,295,0004,762,000

Log in to continue

Log in to see the income statement and 10 historical years.

Log in — it's free

(* All numbers are in thousands)

Balance Sheet

Year202420252026
Total Assets67,443,00075,140,00082,323,000
Total Liabilities69,042,00076,834,00075,407,000
Total Stockholders Equity-1,971,000-2,074,0006,916,000
Total Debt7,390,0007,390,0008,614,000
Cash and Cash Equivalents4,583,0005,691,0003,975,000

Log in to continue

Log in to see the balance sheet and 10 historical years.

Log in — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202420252026
Operating Cash Flow4,314,0006,085,0006,155,000
Capital Expenditure-687,000-859,0000
Free Cash Flow3,627,0005,226,0006,155,000
Net Income3,002,0003,481,0005,099,000
Net Change in Cash-94,0001,371,000-1,888,000

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Log in — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2031Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (Low)559,210,127.527Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (High)585,708,466.797Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (Avg)570,263,000Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (Low)14,848,338.349Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (High)15,693,393.436Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (Avg)15,200,824.100Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (Low)9,989,958.246Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (High)10,609,018.691Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (Avg)10,248,178.082Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (Low)10,359,512.563Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (High)10,850,401.166Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (Avg)10,564,269.890Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (Avg)82.580Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (High)85.490Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (Low)80.500Research AccessResearch AccessResearch AccessResearch Access
Number of Analysts (Estimated Revenue)6Research AccessResearch AccessResearch AccessResearch Access
Number of Analysts (Estimated EPS)2Research AccessResearch AccessResearch AccessResearch Access

Log in to continue

Log in with Research Access to see up to 5 years of analyst estimates.

Create a free account

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
308.951B  ?P/S
 (TTM)
: 
0.3
?Net Income
 (TTM)
: 
3.002B  ?P/E
 (TTM)
: 
28.24
?Enterprise Value
 (TTM)
: 
131.96B  ?EV/FCF
 (TTM)
: 
19.1
?Dividend Yield
 (TTM)
: 
0.31%  ?Payout Ratio
 (TTM)
: 
8.51%
?ROE
 (TTM)
: 
-161.18%  ?ROIC
 (TTM)
: 
29.3%
?Net Debt
 (TTM)
: 
8.475B  ?Debt/Equity
 (TTM)
: 
-2.82
?P/B
 (TTM)
: 
-32.44  ?Current Ratio
 (TTM)
: 
0.9

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Log in — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Research Access for high/low estimates and the interactive table.

Forward P/E 1YResearch AccessResearch AccessResearch AccessResearch Access
28.27Research AccessResearch AccessResearch AccessResearch Access

Log in to continue

Log in with Research Access for forward P/E high/low estimates and the full multi-year table.

Create a free account

SWOT Analysis

🔒 You are currently logged out

Login

It's free

At what price to buy it? -
Intrinsic Value Calculator

Based on current fundamentals and analyst forecasts, MarketSnap estimates MCK intrinsic value between $898.90 – $1,291.38 per share. This depends on revenue growth, margins, and discount rate.

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.


Calculate MCK Intrinsic Value

Common questions about MCK valuation

Is McKesson Corporation (MCK) overvalued or undervalued right now?

MarketSnap estimates intrinsic value for McKesson Corporation (MCK) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is MCK a buy, hold, or sell for long-term investors?

MarketSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether MCK trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is MCK’s P/E ratio?

You can see MCK’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for MCK?

MarketSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MarketSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is MCK a good long-term investment?

Whether MCK fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MarketSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

Research tools for McKesson Corporation

  • McKesson Corporation intrinsic value calculatorEstimate what the business is worth
  • McKesson Corporation 5-year outlookWhat has to go right, and what could go wrong
MCK

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

Daily snapshot

2.39
MarketSnap

Trading Metrics:

Open: 1087.46   Previous Close: 1077.05
Day Low: 1083.84   Day High: 1104.31
Year Low: 723.68   Year High: 1121.5
Price Avg 50: 951.46   Price Avg 200: 872.85
Volume: 527372   Average Volume: 860825

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Log in — it's free
See in Nexus

Relevant news

Here is What to Know Beyond Why McKesson Corporation (MCK) is a Trending Stock
11-11-2026 17:26
Here is What to Know Beyond Why McKesson Corporation (MCK) is a Trending Stock
McKesson (MCK) Upgraded to Buy: Here's What You Should Know
06-11-2026 13:01
McKesson (MCK) Upgraded to Buy: Here's What You Should Know
McKesson Corporation (MCK) Hit a 52 Week High, Can the Run Continue?
06-11-2026 10:16
McKesson Corporation (MCK) Hit a 52 Week High, Can the Run Continue?
MCK Q2 Earnings Call Highlights Raised Outlook and Specialty Growth
05-11-2026 14:30
MCK Q2 Earnings Call Highlights Raised Outlook and Specialty Growth
MCK Q2 Earnings Beat Estimates on Specialty Growth, Outlook Raised
05-11-2026 10:01
MCK Q2 Earnings Beat Estimates on Specialty Growth, Outlook Raised
Will MCK's Pharma & Specialty Demand Offset Pricing Headwind in Q2?
03-11-2026 10:16
Will MCK's Pharma & Specialty Demand Offset Pricing Headwind in Q2?

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

How MarketSnap works

What’s new

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States

Language

    • Gainers & Losers
    • Most Active & More
    • 52-Week High/Low
    • Dividends
      • Large Caps
      • Absolute
      • Total Market PE
      • Large Caps
      • Absolute
      • Industry
      • Sector
    • Analyze a stockAnalyze MCK →
    • FindStock Picks / Stock Screener
    • Value · MCKIntrinsic Value Calculator
    • Invest · MCKInvestment Case
    • Hold · MCK5-Year Outlook
  • Learn
  • Calendar
  • Investment Compounding Calculator
    • Charts
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Investing Philosophy
  • Nexus
    • Recent Activity
      • Overview
      • My Valuations
      • My Investment Journal
      • Watchlists & Portfolio
    • Settings
    • Public profile ↗
  • Log in

Media

Watch Listen Read
Ask MarketSnap AI

MarketSnap AI Assistant

Uses MarketSnap data and this page

Ready

🔒 You are currently logged out

Login

It's free

MarketSnap Assistant · Tips
    MarketSnap

    Welcome to MarketSnap

    The AI-powered workspace for stock pickers.

    Continue with Google Continue with email

    Already a member? Sign in

    Find stocks·Value them·Build the case·Journal decisions·Track what changes

    Free to join. No card needed. Privacy Policy

    Create your free MarketSnap account Continue with Google
    Chat with us MarketSnap support · account, plans, settings, help
    How MarketSnap works

    The conversation above goes to the MarketSnap team with your message. We reply by e-mail.